Metathesis-based synthesis of 3-methoxy α,β-unsaturated lactones: total synthesis of (R)-kavain and of the C1-C6 fragment of jerangolid D

Tetrahedron Letters

Volumn 49, Issue 9, 2008, Pages 1523-1526

  Pospíšil, Jiří ^a   Markó, István E ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Jerangolid D; Julia olefination; Kavain; Metathesis; Sulfoxide modified Julia olefination

Indexed keywords

DIMETHYL DEXTRO MALATE; ETHER DERIVATIVE; JERANGOLID D; KAWAIN; LACTONE DERIVATIVE; MALIC ACID DERIVATIVE; SULFOXIDE; UNCLASSIFIED DRUG; VINYL DERIVATIVE;

ARTICLE; BIOTRANSFORMATION; CATALYSIS; CATALYST; CYCLIZATION; DRUG SYNTHESIS; OLEFINATION; QUANTUM YIELD; REACTION ANALYSIS; RING CLOSING METATHESIS;

EID: 38649100324     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2007.12.113     Document Type: Article

References (50)

1. For a review see:. Collins I. J. Chem. Soc., Perkin Trans. 1 (1999) 1377-1395
2. For recent examples see:. Pospíšil J., and Markó I.E. Tetrahedron Lett. 47 (2006) 5933-5937
3. Gobbini M., and Cerri A. Curr. Med. Chem. 12 (2005) 2343-2355
4. de Fatima A., and Pilli R.A. Tetrahedron Lett. 44 (2003) 8721-8724
5. de Fatima A., and Pilli R.A. ARKIVOC 10 (2003) 118-126
6. Bruckner R. Curr. Org. Chem. 5 (2001) 679-718
7. Job A., Wolberg M., Muller M., and Enders D. Synlett (2001) 1796-1798
8. Zhao G., Wu B., Wu X.Y., and Zhang Y.Z. Mini-Rev. Org. Chem. 2 (2005) 333-354
9. Yet L. Chem. Rev. 103 (2003) 4283-4306
10. Mereyala H.B., and Joe M. Curr. Med. Chem. - Anti-Cancer Agents 1 (2001) 293-300
11. Leclercq C., and Markó I.E. Tetrahedron Lett. 46 (2005) 7229-7233
12. De Dobbeleer C., Ates A., Vanherk J.-C., and Markó I.E. Tetrahedron Lett. 46 (2005) 3889-3893
13. Markó I.E., Dumeunier R., Leclercq C., Leroy B., Plancher J.-M., Mekhalfia A., and Bayston D.J. Synthesis (2002) 958-972
14. Lebot V., Merlin M., and Lindstrom L. Kava-the Pacific Elixir: The Definitive Guide to its Ethnobotany, History, and Chemistry (1997), Healing Arts Press, Rochester, VT
15. Pittler M.H., and Ernst E. J. Clin. Psychopharm. 20 (2000) 84-89
16. Smith K.K., Dharmaratne H.R.W., Feltenstein M.W., Broom S.L., Roach J.T., Nanayakkara N.P.D., Khan I.A., and Sufka K.J. Psychopharmacology 155 (2001) 86-90
17. Jamieson D.D., and Duffield P.H. Clin. Exp. Pharmacol. Physiol. 17 (1990) 495-500
18. Wu D., Yu L., Nair M.G., DeWitt D.L., and Ramsewak R.S. Phytomedicine 9 (2002) 41-47
19. Gleitz J., Beile A., Wilkens P., Ameri A., and Peters T. Planta Med. 63 (1997) 27-30
20. Schmitz D., Zhang C.L., Chatterjee S.S., and Heinemann U. Arch. Pharmacol. Toxicol. 351 (1995) 348-355
21. Seitz U., Ameri A., Pelzer H., Gleitz J., and Peters T. Planta Med. 63 (1997) 303-306
22. Reichenbach, H.; Höfle, G.; Gerth, K.; Washausen, P. PCT Int. Appl. 1997, DE 19607702, CAN 127:219644.
23. Gerth K., Washausen P., Höfle G., Irschik H., and Reichenbach H. J. Antibiot. 49 (1996) 71-75
24. Ringel S.M., Greenough R.C., Roemer S., Connor D., Gutt A.L., Blair B., Kanter G., and von Strandmann M. J. Antibiot. 30 (1977) 371-378
25. Connor D.T., Greenough R.C., and von Strandtmann M. J. Org. Chem. 42 (1977) 3664-3669
26. Knauth P., and Reichenbach H. J. Antibiot. 53 (2000) 1182-1190
27. Saito S., Hasegawa T., Inaba M., Nishida R., Fujii T., Nomizu S., and Moriwake T. Chem. Lett. (1984) 1389-1392
28. Saito S., Ishikawa T., Kuroda A., Koga K., and Moriwake T. Tetrahedron 48 (1992) 4067-4086
29. Alcohol 7 was obtained as a 12:1 mixture of the C6 and C5 monosilylated diols. See Table S-1 (Supplementary information).
30. Okazoe T., Takai K., Oshima K., and Utimoto K. J. Org. Chem. 52 (1987) 4410-4412
31. Allwein S.P., Cox J.M., Howard B.E., Johnson H.W.B., and Rainier J.D. Tetrahedron 58 (2002) 1997-2009
32. For the reaction optimization, see Table S-2 (Supplementary information).
33. Okada A., Ohshima T., and Shibasaki M. Tetrahedron Lett. 42 (2001) 8023-8027
34. Use in total synthesis. Holson E.B., and Roush W.R. Org. Lett. 4 (2002) 3719-3722
35. Taillier C., Gille B., Bellosta V., and Cossy J. J. Org. Chem. 70 (2005) 2097-2108
36. Majumder U., Cox J.M., Johnson H.W.B., and Rainier J.D. Chem. Eur. J. 12 (2006) 1736-1746
37. Johnson H.W.B., Majumder U., and Rainier J.D. Chem. Eur. J. 12 (2006) 1747-1753
38. Schrock R.R. Tetrahedron 55 (1999) 8141-8153
39. Trnka T.M., and Grubbs R.H. Acc. Chem. Res. 34 (2001) 18-29
40. Stork G., Mook Jr. R., Biller S.A., and Rychnovsky S.D. J. Am. Chem. Soc. 105 (1983) 3741-3742 Alternatively, initial reaction of GC-2 with the enol ether function rather than the acrylate might lead to a poorly active Fisher-type carbene. By shifting to an acetal, preferential addition on C1-C2 takes place
41. VanAllan J.A. Org. Synth. 32 (1952) 5-8
42. Interestingly, the same reaction conditions were applied to the cyclization of 4, but only very low conversion (∼20%) was observed.
43. For an alternative synthesis, leading to the jerangolid D C1-C6 fragment, see:. Pospíšil J., and Markó I.E. J. Am. Chem. Soc. 129 (2007) 3516-3517
44. Previous total synthesis of (R)-kavain 2. Smith T.E., Djang M., Velander A.J., Downey C.W., Carroll K.A., and Alphen S.V. Org. Lett. 6 (2004) 2317-2320
45. Wang F.-D., and Yue J.-M. Synlett (2005) 2077-2079
46. Sabitha G., Sudhakar K., and Yadav J.S. Tetrahedron Lett. 47 (2006) 8599-8602
47. Pospíšil J., Pospíšil T., and Markó I.E. Org. Lett. 7 (2005) 2373-2376
48. Pospíšil J., Pospíšil T., and Markó I.E. Collect. Czech Chem. Commun. 70 (2005) 1953-1969
49. Pospíšil J., and Markó I.E. Tetrahedron Lett. 47 (2006) 5933-5937
50. 23a